Atara Biotherapeutics, Inc.

/Atara Biotherapeutics, Inc.

They are a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.

Symbol

Last Closing Price
$19.25

Shares
5,500,000

Effective Date
January 4, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange